- Home
- PXS vs IMMX Comparison
PXS vs IMMX Comparison
Compare PXS & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXS
- IMMX
- Stock Information
- Founded
- PXS 2015
- IMMX 2014
- Country
- PXS Greece
- IMMX United States
- Employees
- PXS N/A
- IMMX N/A
- Industry
- PXS Marine Transportation
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- PXS Consumer Discretionary
- IMMX Health Care
- Exchange
- PXS Nasdaq
- IMMX Nasdaq
- Market Cap
- PXS 44.0M
- IMMX 61.1M
- IPO Year
- PXS N/A
- IMMX 2021
- Fundamental
- Price
- PXS $3.56
- IMMX $2.17
- Analyst Decision
- PXS Strong Buy
- IMMX Strong Buy
- Analyst Count
- PXS 1
- IMMX 1
- Target Price
- PXS $10.00
- IMMX $7.00
- AVG Volume (30 Days)
- PXS 39.8K
- IMMX 269.5K
- Earning Date
- PXS 11-22-2024
- IMMX 11-12-2024
- Dividend Yield
- PXS N/A
- IMMX N/A
- EPS Growth
- PXS 63.38
- IMMX N/A
- EPS
- PXS 2.85
- IMMX N/A
- Revenue
- PXS $52,756,000.00
- IMMX N/A
- Revenue This Year
- PXS $9.36
- IMMX N/A
- Revenue Next Year
- PXS $4.93
- IMMX $200.00
- P/E Ratio
- PXS $1.25
- IMMX N/A
- Revenue Growth
- PXS 4.27
- IMMX N/A
- 52 Week Low
- PXS $3.41
- IMMX $1.26
- 52 Week High
- PXS $5.53
- IMMX $7.50
- Technical
- Relative Strength Index (RSI)
- PXS 32.19
- IMMX 53.37
- Support Level
- PXS $3.41
- IMMX $1.88
- Resistance Level
- PXS $3.62
- IMMX $2.44
- Average True Range (ATR)
- PXS 0.13
- IMMX 0.32
- MACD
- PXS 0.01
- IMMX -0.02
- Stochastic Oscillator
- PXS 34.83
- IMMX 34.94
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company that focuses on the product tanker sector. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Pyxis Epsilon, Pyxis Theta, Pyxis Malou, Northsea Alpha, and Northsea Beta. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.